| ... | ... | @@ -12,7 +12,7 @@ |
|
|
|
* Duran-Frigola et al., *A chemo-centric view of human health and disease*, Nature Communications (2014) [[paper](https://www.nature.com/articles/ncomms6676)]
|
|
|
|
* Duran-Frigola et al., *Drug repositioning beyond the low-hanging fruits*, Current Opinion in Systems Biology (2017) [[paper](https://www.sciencedirect.com/science/article/pii/S2452310016300142)]
|
|
|
|
* Duran-Frigola and Aloy, *Analysis of chemical and biological features yields mechanistic insights into drug side effects*, Chemistry and Biology (2013) [[paper](https://www.sciencedirect.com/science/article/pii/S107455211300121X)]
|
|
|
|
* Jaeger, Duran-Frigola et al., *Drug sensitivity in cancer cell lines is not tissue specific*, Molecular cancer (2015) [[paper](https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-015-0312-6)]
|
|
|
|
* Jaeger, Duran-Frigola et al., *Drug sensitivity in cancer cell lines is not tissue specific*, Molecular Cancer (2015) [[paper](https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-015-0312-6)]
|
|
|
|
* Fernández-Torras et al., *Encircling the regions of the pharmacogenomic landscape that determine drug response*, Genome Medicine (2019) [[paper](https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-019-0626-x)]
|
|
|
|
* Juan-Blanco et al., *Rationalizing drug response in cancer cell lines*, Journal of Molecular Biology (2018) [[paper](https://www.sciencedirect.com/science/article/pii/S0022283618301700)]
|
|
|
|
* Duran-Frigola, Mosca and Aloy, *Structural systems pharmacology: the role of 3D structures in next-generation drug development*, Chemistry and Biology (2013) [[paper](https://www.sciencedirect.com/science/article/pii/S1074552113000872)]
|
| ... | ... | |
